Evaluation of the Efficacy of a Coordinated Interprofessional Care Pathway on Disability in Patients With Chronic and at Risk of Chronic Low Back Pain in Primary Care

NCT ID: NCT05531201

Last Updated: 2025-07-20

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

150 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-02-15

Study Completion Date

2026-11-13

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Low back pain is a public health problem with major individual and socio-economic repercussions. In primary care, strong disparities are observed in the management of low back pain patients. While general practitioners (GPs) and physiotherapists appear as two essential first-line caregivers, collaboration between these professionals remains underdeveloped, most often characterized by a lack of consultation or coordination. Systematic increased interprofessional collaboration is likely to improve the results of the care pathway, by optimizing the existing care offer.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Low Back Pain

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Interventional

Trainig of GP and physiotherapist at collaborative coordinated care pathway

Group Type EXPERIMENTAL

collaboration general practitioner and physiotherapist

Intervention Type PROCEDURE

training general practitioner and physiotherapist

Control

without modification of the usual follow-up

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

collaboration general practitioner and physiotherapist

training general practitioner and physiotherapist

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Adult patients between the ages of 18 and 65

* Patients consulting their GP for a first or new eisode of acute low back pain (more than 12 months from the previous one) with a STarT Back screening tool score greater than 3.
* OR low back pain at risk of chronicity (presence of yellow flags, according to the recommendation of the High Health Authority (HAS) of 2019
* OR recurrent low back pain: in the event of recurrence of low back pain within 12 months after the previous episode, then considered to be at risk of chronicity
* OR having chronic low back pain (low back pain for more than 3 months)
* Patients benefiting from the general social security system
* Patients who understand and speak French fluently
* Patients who have given their consent after having received complete information on the protocol

Exclusion Criteria

* Minor patients
* Pregnant women (declared pregnancy) or immediately postpartum (up to 3 months)
* Patients with "red flags" (serious neurological impairment, cancer, infection, fracture or inflammatory disease), according to the 2019 HAS recommendation
* Patients referred immediately for imaging or specialist advice during the first consultation with the GP (suspicion of underlying pathology)
* Patients with no history of acute low back pain, at low risk of chronicity (STarT Back screening tool score less than or equal to 3)
* Patients with a contraindication to rehabilitation by physiotherapy
* Patients who have already undergone spine surgery
* Patients with cognitive impairment
* Patients whose life expectancy is less than 12 months
* Patients under guardianship or curatorship, under judicial protection or safeguard of justice
* Patients not affiliated to the general social security system
* Patients with difficulties in understanding the French language
* Patients with an inability to give express consent
Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

CNGE Conseil

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Tan-Trung PHAN

Role: STUDY_CHAIR

Département Universitaire d'Enseignement et de Recherche en Médecine Générale - Université Paris-Est Créteil, 8 rue du Général Sarrail 94010 Créteil Cedex

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Maison de Santé Pluriprofessionnelle Universitaire

Fontainebleau, , France

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Tan-Trung PHAN

Role: CONTACT

01 85 48 12 34/06 63 48 53 81

Julien LE BRETON

Role: CONTACT

06 64 00 91 07

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Tan-Trung PHAN, Dr

Role: primary

01 85 48 12 34

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2021-A02432-39

Identifier Type: REGISTRY

Identifier Source: secondary_id

CNGE-2021/01

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.